| 发明名称 | Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist | ||
| 摘要 | A composition for treating or preventing glaucoma or ocular hypertension including a isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate and a beta-receptor antagonist, in a combined pharmaceutically acceptable amount. As for the administration form, these drugs may be administered concomitantly or may be administered as a combination drug. | ||
| 申请公布号 | US9339496(B2) | 申请公布日期 | 2016.05.17 |
| 申请号 | US201313939381 | 申请日期 | 2013.07.11 |
| 申请人 | SANTEN PHARMACEUTICAL CO., LTD. | 发明人 | Kirihara Tomoko;Shimazaki Atsushi;Nakamura Masatsugu |
| 分类号 | A61K31/444;A61K45/06;C07D401/14;A61K31/498;A61K31/5377;A61K31/542;A61K31/5575 | 主分类号 | A61K31/444 |
| 代理机构 | Holtz, Holtz & Volek PC | 代理人 | Holtz, Holtz & Volek PC |
| 主权项 | 1. A composition for treating glaucoma or ocular hypertension comprising 0.001 to 0.1 w/v % of isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate and 0.1 to 0.5 w/v % of timolol, in a combined pharmaceutically effective amount, wherein the isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate may be in the form of a salt thereof, and the timolol may be in the form of a salt thereof. | ||
| 地址 | Osaka JP | ||